JP2011523642A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011523642A5 JP2011523642A5 JP2011509995A JP2011509995A JP2011523642A5 JP 2011523642 A5 JP2011523642 A5 JP 2011523642A5 JP 2011509995 A JP2011509995 A JP 2011509995A JP 2011509995 A JP2011509995 A JP 2011509995A JP 2011523642 A5 JP2011523642 A5 JP 2011523642A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- expression vector
- replicase
- adjuvant
- vaccine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7189808P | 2008-05-23 | 2008-05-23 | |
| US61/071,898 | 2008-05-23 | ||
| PCT/EP2009/056240 WO2009141434A1 (en) | 2008-05-23 | 2009-05-22 | Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011523642A JP2011523642A (ja) | 2011-08-18 |
| JP2011523642A5 true JP2011523642A5 (https=) | 2013-05-23 |
| JP5663474B2 JP5663474B2 (ja) | 2015-02-04 |
Family
ID=40910781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011509995A Expired - Fee Related JP5663474B2 (ja) | 2008-05-23 | 2009-05-22 | アルファウイルスレプリカーゼをコードする発現ベクターおよび免疫アジュバントとしてのその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9474800B2 (https=) |
| EP (1) | EP2296702A1 (https=) |
| JP (1) | JP5663474B2 (https=) |
| KR (1) | KR20110044836A (https=) |
| CN (1) | CN102083463B (https=) |
| AU (1) | AU2009248735B2 (https=) |
| BR (1) | BRPI0913045A2 (https=) |
| CA (1) | CA2724570A1 (https=) |
| IL (1) | IL209077A0 (https=) |
| MX (1) | MX2010012587A (https=) |
| NZ (1) | NZ589495A (https=) |
| RU (1) | RU2010152562A (https=) |
| SG (1) | SG191600A1 (https=) |
| WO (1) | WO2009141434A1 (https=) |
| ZA (1) | ZA201007880B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201220119D0 (en) * | 2012-11-08 | 2012-12-26 | Univ Cork | Vector |
| CN111304201B (zh) * | 2020-02-21 | 2022-10-21 | 华南农业大学 | 一种降低乙型脑炎脑病毒感染的siRNA及其应用 |
| AU2021236068A1 (en) * | 2020-03-09 | 2022-10-06 | Arcturus Therapeutics, Inc. | Compositions and methods for inducing immune responses |
| EP4196128A4 (en) | 2020-08-14 | 2024-06-12 | Arcturus Therapeutics, Inc. | METHOD FOR FREEZE DILIZATION OF LIPID NANOPARTICLES |
| CN113846113B (zh) * | 2021-09-09 | 2022-09-13 | 臻赫医药(杭州)有限公司 | 一种有限自我复制mRNA分子系统、制备方法及应用 |
| EP4460564A4 (en) * | 2022-01-08 | 2026-02-11 | Carogen Corp | MULTI-ANTIGEN THERAPEUTIC VACCINES TO TREAT OR PREVENT CHRONIC HEPATITIS B VIRUS INFECTION |
| KR20240049429A (ko) | 2022-10-08 | 2024-04-16 | 최주언 | 황금비율 계량컵 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763584A (en) * | 1992-05-18 | 1998-06-09 | Genentech, Inc. | Receptor activation with hepatocyte growth factor agonists |
| SE9401091D0 (sv) * | 1994-03-31 | 1994-03-31 | Bioption Ab | Alphavirus cDNA vectors |
| SE9401709D0 (sv) * | 1994-05-18 | 1994-05-18 | Mathilda Sjoeberg | Improved alphavirus vectors for expression of heterologous DNA |
| US6451579B1 (en) * | 1998-07-29 | 2002-09-17 | Invitrogen Corporation | Regulated expression of recombinant proteins using RNA viruses |
| WO2001030989A2 (en) * | 1999-10-27 | 2001-05-03 | Cytos Biotechnology Ag | Method for creating divergent populations of nucleic acid molecules and proteins |
| US7592005B2 (en) * | 2000-12-28 | 2009-09-22 | Kirin Beer Kabushiki Kaisha | Monoclonal antibody |
| FI116851B (fi) * | 2001-05-03 | 2006-03-15 | Fit Biotech Oyj Plc | Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita |
| WO2004018506A2 (en) * | 2002-08-22 | 2004-03-04 | Cytos Biotechnology Ag | Inducible alphaviral/orip based gene expression system |
| ES2222095B1 (es) * | 2003-07-02 | 2005-11-16 | Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria Inia | Virus adn recombinantes que comprenden un adn complementario de un replicon de un virus arn y sus aplicaciones. |
| EP1773403B1 (en) * | 2004-07-09 | 2018-04-25 | The University of North Carolina At Chapel Hill | Alphavirus-based adjuvants |
| ES2746960T3 (es) * | 2006-09-12 | 2020-03-09 | Alphavax Inc | Partículas de replicón de alfavirus que codifican IL-12 como adyuvantes inmunológicos |
| HRP20100638T2 (hr) * | 2006-11-28 | 2011-03-31 | Proyecto De Biomedicina Cima | Viralni vektori i njihova uporaba |
| WO2008119827A1 (en) * | 2007-04-02 | 2008-10-09 | Fit Biotech Oy | Transreplicase constructs |
-
2009
- 2009-05-22 BR BRPI0913045A patent/BRPI0913045A2/pt not_active IP Right Cessation
- 2009-05-22 NZ NZ589495A patent/NZ589495A/en not_active IP Right Cessation
- 2009-05-22 CA CA2724570A patent/CA2724570A1/en not_active Abandoned
- 2009-05-22 JP JP2011509995A patent/JP5663474B2/ja not_active Expired - Fee Related
- 2009-05-22 RU RU2010152562/10A patent/RU2010152562A/ru not_active Application Discontinuation
- 2009-05-22 US US12/993,987 patent/US9474800B2/en not_active Expired - Fee Related
- 2009-05-22 MX MX2010012587A patent/MX2010012587A/es not_active Application Discontinuation
- 2009-05-22 AU AU2009248735A patent/AU2009248735B2/en not_active Ceased
- 2009-05-22 CN CN200980118773.7A patent/CN102083463B/zh not_active Expired - Fee Related
- 2009-05-22 WO PCT/EP2009/056240 patent/WO2009141434A1/en not_active Ceased
- 2009-05-22 KR KR1020107029034A patent/KR20110044836A/ko not_active Ceased
- 2009-05-22 EP EP09749924A patent/EP2296702A1/en not_active Withdrawn
- 2009-05-22 SG SG2013039953A patent/SG191600A1/en unknown
-
2010
- 2010-11-02 IL IL209077A patent/IL209077A0/en unknown
- 2010-11-03 ZA ZA2010/07880A patent/ZA201007880B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021182922A5 (https=) | ||
| JP2011523642A5 (https=) | ||
| Pugachev et al. | Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection | |
| JP5065024B2 (ja) | Ｔｃ−８３由来アルファウイルスベクター、粒子および方法 | |
| KR101196178B1 (ko) | Ｈｉｖ 조절/부속 단백질의 융합 단백질 | |
| ES2576036T3 (es) | Métodos de vacunación | |
| JP2017503482A5 (https=) | ||
| MX2009008118A (es) | Polipeptido e2 del virus del papiloma usado para vacunacion. | |
| JP2012509678A5 (https=) | ||
| JPH05502999A (ja) | 治療用リボザイム組成物および発現ベクター | |
| US11638751B2 (en) | Immunogenic composition comprising a recombinant attenuated mopeia virus with a modified nucleoprotein displaying reduced exonuclease activity | |
| JP2016513115A5 (https=) | ||
| EA003554B1 (ru) | Фармацевтическая композиция для генерации противовирусного иммунного ответа у человека и животного | |
| JP2013502225A5 (https=) | ||
| WO2009141434A4 (en) | Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant | |
| JP2024535145A5 (https=) | ||
| RU2015113826A (ru) | Выделение вируса, родственного парвовирусу-2 собак, от енота | |
| Cervantes-Barragan et al. | Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity | |
| US8765143B2 (en) | Fusion proteins and use thereof for preparing hepatitis C vaccines | |
| JP7841847B2 (ja) | ラッサワクチン | |
| JP2017518058A (ja) | 弱毒ｒｎａウイルスの迅速な生成のための方法 | |
| CN102746387B (zh) | 一种hcv的dna疫苗及其制备方法 | |
| CN112501138A (zh) | 用于快速制备感染性rna病毒的方法 | |
| WO2009126308A3 (en) | Compositions and methods for vaccine and virus production | |
| WO2004072274A1 (en) | Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier |